Metformin has the capacity to reduce tumour proliferation in a multitude of mechanisms that include reducing circulating insulin and glucose levels as well as regulating the expression of various cell signalling pathways involved in the regulation of insulin and glucose metabolism [49]. This evidence concerns the gene INS and neoplasm.